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Hypertension, while usually easily handled , can in certain patients present difficult
problems in management.

Previous Neurological Disease
A history of stroke sometimes creates
doubt as to the advisability of lowering the blood
pressure as this might reduce flow to the brain ,
causing the patient to have another stroke. It is
recognized that severe hypertensives clearly do
better if they are treated, ' ·2 but the mild-to-modera te hypertensive patient with a history of
stroke is a more difficult problem , and uncertainty about proper management has been so
great that a large multicenter clinical trial-random i zed, double-blind , and placebo-controlled-of 452 patients was done by the
Stroke-Hypertensive Study group , and its results
reported in 1974. 3 All 452 patients had a history of a previous stroke and all had mild-tomoderate diastolic hypertension . This study
showed that long-term outpatient treatment of
the blood pressure neither caused nor prevented a second stroke. Other benefits such as
a reduction in the number of episodes of congestive heart failure were evident in the treated
group. It would seem, then, that patients with a
history of stroke should be treated for their diastolic hypertension, unless there are other contraindications.
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Isolated Systolic Hypertension
Another difficult problem is that of "isolated systolic hypertension ," that is , blood pressure of 1 80 / 7 4 mm Hg , a condition common
among older people.
Data from the Framingham study have
shown that the age-corrected morbidity ratio is
correlated with systolic or diastolic hypertension
or both ,4 as it is for stroke, congestive heart failure, and renal disease. Increased systolic blood
pressure is therefore clearly a risk factor for cardiovascular damage, and one might assume
that it ought to be lowered. Of the large, carefully conducted blood pressure treatment trials
that show patient benefit (decreased death or
morbidity) , all required that patients have diastolic hypertension to get into the study and did
not include those with such pressures as 180 I
7 4 mm Hg; these might have a stiff aorta and
great vessels , requiring a high systolic pressure
to pump a given stroke volume into the vascular
system . In addition, treatment of the patient's
180 mm Hg systolic pressure will also lower the
diastolic pressure, which may be undesirable.
Symptomless coronary heart disease does exist, and blood flow through the coronary arteries
is, of course, heavily dependent upon diastolic
pressure, even more so in the presence of diseased arteries.
When encountering a patient with a wide
pulse pressure or with a severe systolic hypertension and normal diastolic pressure , one
should look for aortic insufficiency. Severe
anemia , arteriovenous fistula, or thyrotox!cosis
can also produce systolic hypertension.
Once these conditions are ruled out, the

decision to treat or not to treat must be faced.
Unfortunately, there are no data to indicate that
such patients can be helped by treating their
isolated systolic hypertension. In the face of this
uncertainty, treatment is recommended only
when the patient has clear evidence of definite
cardiovascular damage that appears to be due
to the hypertension per se; definite left ventricular hypertrophy might be present, for example,
with no other explanation.
The systolic blood pressure usually rises
with age in the American population 5 which puts
some millions of primarily elderly people at risk
for untreated hypertension or at risk for treatment-induced complications. This is an important clinical problem that has not yet had the
systematic and careful study which it deserves.
i

Mild Diastolic Hypertension
.Whether or not to treat mild diastolic high
blood pressure (96 mm Hg) may also cause uncertainty, but the Veterans Administration Cooperative Study Group, interpreted by Doctor
Freis, has helped to clarify this question. 6 If the
diastc)lic blood pressure is high enough (over
1 04 mm Hg), one should go ahead and treat on
the basis of the blood pressure alone . At lower
levels, the presence of "risk factors" for hypertensi,,e damage should be sought. These include the usual risk factors for atherosclerosis,
such as hypercholesterolemia, diabetes, family
history, obesity, among others, and age (youth),
and race (black). If several risk factors for hypertensive damage are present, or if cardiovascular
damage itself is already evident, one should
treat the patient with borderline hypertension.
Lack of Response to Therapy
Occasionally, a patient may not respond
to the prescribed medication . One reason for
this might be incorrect cuff size. In dealing with
an obese patient, this can be an important factor, causing as much as 1 O mm Hg diastolic
error, or more. Current recommendations of the
American Heart Association are for a cuff (bladder) width "25% greater than the diameter of
the arm"; thus, the standard cuff bladder, 12 x
2 2 cm, is suitable for a 1 0 cm (4-inch) diameter
arm.
Other reasons why the patient may not be
responding to treatment could involve technical
factors. For instance, if the patient is engaged in
conversation while the pressure is being taken ,

the diastolic blood pressure rises slightly. A cold
room also raises the blood pressure, systolic
and diastolic, as does recent cigarette smoking
or an office "climate" that is rushed and hurried . A number of referrals have turned out to be
patients who are able to recall that the office atmosphere in which their blood pressure was
previously taken was hectic, or that they themselves were very rushed and hurried.
Another reason for non-response is that
the patient may not be taking his or her medication. An estimated 25% to 50% of patients (depending upon definitions used) will be "noncompliant.' ' Sometimes these individuals return
regularly to see their doctor, even though they
are not taking their medication; they may even
count out the appropriate number of pills and
throw them in the trash, so that the number remaining in the bottle appears to be correct to
the physician. The best weapon against this is a
good doctor-patient relationship in which the
patient is assured of the physician's interest.
For example , it helps to ask the patient if he or
she is taking the prescribed medication regularly. If the answer is yes and the patient seems
to be certain about it, the physician should inquire if the medication was taken on schedule
that day and the night before . If the patient appears at all uncertain, the physician can then
describe the difficulty created by not following
treatment , and how this can inadvertently cause
over-treatment. Patient education as to the nature of the disease and how complications are
avoided has been carefully studied as a means
to help compliance, but it has not been as successful as had been hoped.
Simplicity of treatment is very important .
Most antihypertensive medications need only be
taken twice a day at most. Drug combinations
may help if the right combination can be found
to fit the patient's needs.
A patient may be complying with prescribed medication and yet still not respond to
treatment . The most common cause for this is
subtle fluid retention . The body can retain anywhere from 5 to 11 pounds (depending on body
size) of extra fluid without producing obvious
edema that can be detected on physical examination; thus , a severe hypertensive should be
weighed on every office visit. The extra fluid can
be eliminated by salt restriction or by more powerful diuretics; this will often restore the responsiveness of the patient to the same program of
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antihypertensive medication . Frank congestive
heart failure also interferes with the response to
medications, as does deteriorating renal function, when blood pressure medicines can become ineffective.

Malignant (Accelerated) Phase of Hypertension
Non-response to treatment may be
caused by the fact that the patient is entering
the malignant phase of hypertension; high diastolic pressures (130 mm Hg) will be present .
This is, of course, a body-wide problem; the
basic lesion, fibrinoid necrosis, occurs in arterioles all over the body. The condition can be
diagnosed in the office by the following clinical
manifestations:
1 . Acute hypertensive retinitis or retinopathy: flame-shaped hemorrhages,
and fluffy exudates , perhaps with papilledema.
2 . Hypertensive encephalopathy: diffuse
cerebral dysfunction, perhaps with
somnolence , coma, and/or convulsions.
3 . Malignant nephrosclerosis: microscopic
or gross hematuria and proteinuria
These manifestations are totally curable
by lowering the blood pressure to normal, unless the renal lesion has progressed far enough
to produce gross decrease in renal function, at
which point renal damage may be arrested or
slowed , but not cured.
Once malignant hypertension has been
halted , the prognosis is still poor. However, as
long as the blood pressure is kept down , this
syndrome will not return. Patients with newlydiscovered malignant hypertension should be
hospitalized for immediate control of the blood
pressure.
Secondary Hypertension
Trouble may occur with pressure control
when the patient has an unrecognized cause of
high blood pressure . Pheochromocytoma is a
classic example and these patients have notoriously erratic blood pressure that is very difficult
to control . Coarctation of the aorta can cause
real trouble as very satisfactory blood pressure
levels may be produced below the coarctation
and yet be uncontrollable above the coarctation. Perhaps the patient is on birth-control hormones which in some cases can cause pro66 /
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nounced hypertension. The possible use of
artificial female hormones should be ascertained in women of childbearing age or even
post-childbearing years.

Severe Hypertension
Severe hypertension can be difficult to
manage . Hemodynamic studies have shown
that these patients have normal cardiac output,
normal heart rate, normal stroke volume, and
normal cerebral blood flow unless they are in
heart failure or severe renal failure. Subtle alterations in blood flow to several other parts of the
body occur and renal blood flow is usually reduced. The small arterioles, because of their
size, offer extremely high resistance to blood
flow throughout the body . Treatment should begin with a diuretic, not because there will be an
adequate response to the diuretic alone but because it decreases the amount of other medications that are required, and is therefore a reasonable foundation for therapy.
Hydrochlorothiazide is usually used, 50
mg twice a day, unless fluid retention is a problem, in which case furosemide is used; a lowsalt diet can help, as can weight loss if the patient is grossly obese . It is extremely difficult to
get a grossly obese patient to lose weight, but
when successful, the weight loss will lower the
blood pressure to a surprising degree.
Of course, other medications are going to
be needed in addition to the thiazide. Methyldopa or propranolol could be added . Methyldopa is marketed as Aldomet. The highest dose
that does any good in a large patient is a total of
about 3. 5 gm a day divided into two doses.
Beyond that, little, if any , blood pressure
change occurs and there is the possibility of an
increase in toxicity.
Propranolol is marketed as lnderal and is
a beta-receptor blocker . It affects not just the
cardiovascular system but also blocks beta-receptors in the lungs and receptors in the endocrine system, so that there is the possibility of
worsening of the asthmatic patient, or leaving
the labile diabetic patient defenseless against
hypoglycemia. It has recently been found that
larger doses of propranolol are useful, and European and Australian physicians are using up
to 1 gm per day if the patient needs it and can
tolerate it well .7 We have not given quite this
much at the Medical College of Virginia, but we
are gradually moving to higher doses. Exactly

why propranolol has a good effect on the blood
pressure in these high-dosage ranges (beyond
what seems to do any good for angina pectoris)
is something of a mystery. Propranolol is better
tolerated in some ways than guanethidine, and
causes less orthostatic hypotension.
Guanethidine is a useful and powerful
antihypertensive but causes orthostatic hypotension, as well as intestinal and sexual problems. The dose is extremely variable, and must
be individually adjusted, but nearly all hypertensive patients respond favorably to this drug . The
problem is that it can produce intolerable side
effects. Guanethidine and phenoxybenzamine
given together have been shown to be useful in
a few patients who do not respond to guanethidine and a diuretic alone.
A new beta-blocker has been recently
marketed-metoprolol (Lopressor) . It is promoted as being less toxic to the pulmonary and
endocrine systems. There is evidence that it is
especially useful in patients with obstructive
lung disease, although it is not completely devoid of action on pulmonary beta receptors.
If a patient is unresponsive to thiazide plus
propranolol or guanethidine, a vasodilator may
be added. Hydralazine is an excellent vasodilator and would be even more powerful if we
could give enough . Long-term treatment must
be limited to about 200 mg a day for an average-size patient because of a lupus-like syndrome that occurs at higher doses with disturbing frequency. I do not know of a single
convincing case of lupus-like syndrome at MCV
caused by less than 200 mg of hydralazine,
and I have been looking specifically for it for the
last twelve years.
Prazosin (Minipres) has been recently
marketed as a vasodilator. There is some evidence that it has an additional alpha-blockade
effect, but the exact balance between these two
actions is not well known . It is useful up to 20
mg a day.

If all these drugs have been tried and the
hypertension is still uncontrolled, hospitalization
is indicated. At this time the physician can determine if any further action is required , such as
an arteriogram , to eliminate the possibility of
renal artery stenosis if the patient seems to be
otherwise a reasonable surgical candidate for
its correction . Hospitalization also presents an
opportunity to look for other causes of hypertension that might be corrected . Under these
conditions, it is always possible to control the
blood pressure somehow, using parenteral
medications. Later, the patient can be taken off
parenteral medication and put on oral agents.
The patient will usually be more responsive to
the drugs, at least for a while, after hospitalization .
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